Androgen Receptor-Blocking Agents: Potential Role in Pancreatic Cancer

ISSN： 1170-229X

Source： Drugs & Aging, Vol.17, Iss.3, 2000-09, pp. : 161-163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Valsartan and Other Angiotensin Receptor Blocking Agents in the Management of Cardiovascular Disease

By Martin J. Krum H.

Pharmacological Research, Vol. 46, Iss. 3, 2002-09 ,pp. : 203-212

Academic Press

Access to resources Recommend Favorite

Role of platinum agents in the management of advanced pancreatic cancer

By Saif Muhammad Wasif Kim Richard

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 16, 2007-11 ,pp. : 2719-2727

Informa Healthcare

Access to resources Recommend Favorite

The Role of Intracrine Androgen Metabolism, Androgen Receptor and Apoptosis in the Survival and Recurrence of Prostate Cancer During Androgen Deprivation Therapy

Current Drug Targets, Vol. 14, Iss. 4, 2013-04 ,pp. : 420-440

Bentham Science Publishers

Access to resources Recommend Favorite

The Epidemiological, Mechanistic and Potential Clinical Role of Androgen Receptor (AR) in Urothelial Carcinoma

Current Drug Targets, Vol. 17, Iss. 2, 2016-02 ,pp. : 196-205

Bentham Science Publishers

Access to resources Recommend Favorite

Steroid Receptor Ligands for Breast Cancer Targeting: An Insight into Their Potential Role As Pet Imaging Agents

Current Medicinal Chemistry, Vol. 20, Iss. 2, 2013-01 ,pp. : 222-245

Bentham Science Publishers

Access to resources Recommend Favorite